Official Title
SARS-CoV-2/COVID-19 Study of the Audible and Inaudible Vibroacoustic E-stethoscope - imPulse™ Una
Brief Summary

This study generates robust clinical data to train ML/AI algorithms of the Sponsor's imPulse™ Una full-spectrum e-stethoscope for digital diagnostic feature synthesis of symptomatic SARS-CoV-2/COVID-19 biosignatures for rapid and accurate mass screening.

Detailed Description

This study is designed to evaluate the ability of the imPulse™ Una e-stethoscope to
differentiate vibroacoustic signals in inpatients with and without confirmed COVID-19 as the
first step to establish the performance characteristics - sensitivity, specificity, positive
and negative predictive value - of the imPulse™ Una device for early and rapid, point-of-care
diagnosis of COVID-19. This will inform the utility and design of further larger-scale
studies using the device.

Completed
Corona Virus Infection
Coronavirus

Device: imPulse™ Una e-stethoscope

The imPulse™ System is an every/anywhere-point-of-care cardiopulmonary functional state assessment platform designed to capture normal and abnormal, audible and inaudible cardiopulmonary sounds, rhythms and patterns, via a real-time, intelligent, full-spectrum phonocardiogram obtained from direct to skin coupling or through a layer of clothing.

Device: Philips Lumify Ultrasound System

Point-of-care ultrasound

Eligibility Criteria

Inclusion Criteria

- Individuals hospitalized within a Johns Hopkins-affiliated hospital

- Able to understand and willingness to comply with study procedures

- Cases - inpatients with positive COVID-19 PCR test, collected from a respiratory
sample within the last 7 days, AND pulmonary symptoms within 72 hours of enrollment

- Controls - inpatients without COVID-19 diagnosis and no pulmonary diagnosis or
symptoms

- Cases or Control not able to sit or stand will be allowed to participate in just the
parts of the staircase exam they're capable of doing.

Exclusion Criteria

- Assisted ventilation, including high flow nasal cannula, or ventilator support

- Unable to comply with study procedures, defined at investigator's discretion

- Participants with any visible skin infections or open wounds in areas where the
imPulse™ Una device would be applied

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 90 Years
Countries
United States
Locations

Johns Hopkins School of Medicine
Baltimore, Maryland, United States

Level 42 AI, Inc.
NCT Number
Keywords
infrasound
e-stethoscope
biosignature
SARS-CoV-2/COVID-19
MeSH Terms
Coronavirus Infections